Scientists have discovered a compound in python blood that reduces appetite and could lead to safer, more effective weight-loss drugs.

Python has made using Microsoft Excel much easier than it has ever been, and it isn't very hard to start using it yourself.

In a move clearly designed to strengthen its position among developers, OpenAI has acquired Python tool maker Astral. The house of Altman expects the deal to strengthen the ecosystem for its Codex ...

Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain trends, and present findings clearly across business, finance, product, and ...

OpenAI Group PBC today announced plans to acquire Astral Software Inc., a startup with a set of widely used Python development tools.  The terms of the deal were not disclosed. Astral’s development ...

Overview:  Python libraries help businesses build powerful tools for data analysis, AI systems, and automation faster and more efficiently.Popular librarie ...

OpenAI has acquired Astral, a startup whose essential Python development tools are used by millions. This strategic move aims ...

Metabolites from python blood have the potential to lead to the creation of weight-loss medications similar to Ozempic, according to new research. At first, scientists at Stanford University, Baylor ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...